Active surveillance for low-risk papillary thyroid microcarcinoma: a web-survey on clinician readiness for change
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Greek endocrinologists
Area Of Science
- Endocrinology
- Oncology
- Surgical Oncology
Background
- Current guidelines recommend active surveillance (AS) for low-risk papillary thyroid microcarcinomas (PTMCs).
- Minimally invasive treatments like thermal ablation are emerging alternatives.
- Radioactive iodine (RAI) remnant ablation is not routinely advised post-lobectomy for low-risk PTMC.
Purpose Of The Study
- To evaluate Greek endocrinologists' current practices regarding AS and PTMC management.
- To understand the adoption of established guidelines versus alternative treatments.
Main Methods
- A web-based survey was distributed to members of the Hellenic Endocrine Society (HES).
- Participants analyzed clinical scenarios of low-risk PTMC in a 60-year-old woman.
- Respondents indicated preferred primary treatment (AS, thermal ablation, lobectomy, total thyroidectomy) and subsequent RAI ablation if applicable.
Main Results
- 46.8% of 201 endocrinologists recommended total thyroidectomy, while 31.3% favored AS.
- Lobectomy was chosen by 20.9%, and thermal ablation by 1.0%.
- If total thyroidectomy was performed, 95% deemed RAI ablation unlikely, and only 5% would use it. No demographic factors influenced choices.
Conclusions
- One-third of Greek endocrinologists prefer AS for low-risk PTMCs, indicating a partial shift towards guidelines.
- Further efforts are needed to align clinical practice with AS recommendations.
- This study provides insights to minimize overtreatment in low-risk PTMC management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.